Clinical Trial Update: The Bridging Antiplatelet Therapy With Cangrelor 2 Study [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 trial evaluating bridging antiplatelet therapy with cangrelor for coronary artery disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: University of Florida | Conditions: Coronary Arterial Disease (CAD) | Phase 4 | Status: NOT_YET_RECRUITING